Christoph A Gebeshuber
Affiliation: University of Vienna
- Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputsChristoph A Gebeshuber
Institute for Molecular Pathology Vienna, Vienna, Austria
Cells Tissues Organs 185:51-60. 2007..We want to focus on the Wnt-activated transcription factor complex beta-catenin/LEF-1, its upstream activators, its downstream targets and consequences on the cellular level in response to beta-catenin/LEF-1 activation...
- miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasisChristoph A Gebeshuber
IMBA Vienna, Institute for Molecular Pathology, Dr Bohrgasse 3 5, 1030 Vienna, Austria
EMBO Rep 10:400-5. 2009..Previously, miR-29 family members were shown to have tumour-suppressive effects in haematopoietic, cholangiocytic and lung tumours. Therefore, miRNAs can act as either oncogenes or tumour suppressors, depending on the context...
- Annexin A1 attenuates EMT and metastatic potential in breast cancerSabine Maschler
Research Institute of Molecular Pathology, Vienna, Austria
EMBO Mol Med 2:401-14. 2010..AnxA1 knockdown stimulated multiple signalling pathways but only Tyk2/Stat3 and Erk1/2 signalling were essential for EMT...